An underground market for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.
Investigational Treatment Acquiring Traction Via Social Media
Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are urged to message these profiles directly for source information, while also receiving discount codes.
Thriving Commerce on Messaging Platforms
Separately, a robust trade exists on Telegram, where communities with thousands of members share “before and after” photos, injection guides and assertions of next-day UK delivery. Sellers promote the substance there before redirecting buyers to WhatsApp for transactions.
Understanding Retatrutide
Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.
Healthcare Experts Express Worries
However, doctors and chemists have warned that the sale of what remains an unlicensed drug in the UK is a cause for concern and could lead to users injecting substances of unknown origin.
Several experts stated the popularity for the experimental drug could be connected to the increasing price of approved weight loss treatments such as Mounjaro.
Legal Position and Enforcement
Marketing retatrutide on social media or Telegram is prohibited in the UK, as it is an unapproved drug that must not be marketed or distributed for human use under the British medical regulations.
Several content creators attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still breach medicines, advertising, and customer laws, potentially leading to fines, prosecution or prison.
Platform Response and Content Elimination
According to the social media company, the service has taken down violative material and banned related keywords and search suggestions. The company stated it was committed to maintaining the service safe and allocating resources in strengthening enforcement strategies.
Online Marketplace Activities
Research also found groups with up to 9,000 participants selling the experimental drug using the platform's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” instantly displays channels with numerous of users, populated with images of slimming results, positive testimonials and step-by-step guides for mixing or injecting at residence.
After minutes of joining one group, a seller shared WhatsApp details, where most purchases take place. The seller sent an instruction manual and promised delivery within two days. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one inquired about weight, health issues or past usage.
Item Details and Costs
Inside these communities, posts show dark colored parcels with Royal Mail stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors usually priced at 160 pounds for 20 milligrams. When questioned how long a pen should last, vendors give conflicting responses ranging from a several days to “depends on your body”.
Platform Moderation and Security Measures
A spokesperson for Telegram said it regularly moderated harmful material on its service including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are administering materials they cannot confirm. Although the science behind this drug is valid, these digital products may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service connected the increase in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, individuals are using social media. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was clean,” she said.
Her team has previously encountered individuals harmed by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be impure or improperly measured.”
Producer Statement
A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can market [it] for human use,” they said, noting that any product “falsely representing itself as a company experimental substance not yet approved … may subject patients to potentially significant health risks”.
